196 related articles for article (PubMed ID: 30801741)
1. Resistant cutoff values and optimal scheme establishments for florfenicol against Escherichia coli with PK-PD modeling analysis in pigs.
Lei Z; Liu Q; Khaliq H; Cao J; He Q
J Vet Pharmacol Ther; 2019 May; 42(3):324-335. PubMed ID: 30801741
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility breakpoint for Danofloxacin against swine Escherichia coli.
Yang Y; Zhang Y; Li J; Cheng P; Xiao T; Muhammad I; Yu H; Liu R; Zhang X
BMC Vet Res; 2019 Feb; 15(1):51. PubMed ID: 30717803
[TBL] [Abstract][Full Text] [Related]
3. Antibacterial activity of combined aditoprim and sulfamethoxazole against Escherichia coli from swine and a dose regimen based on pharmacokinetic-pharmacodynamic modeling.
Wang F; Luo W; Pan Y; Qu W; Xie S; Huang L; Wang Y
J Vet Pharmacol Ther; 2022 Jan; 45(1):133-145. PubMed ID: 34435681
[TBL] [Abstract][Full Text] [Related]
4. PK-PD Integration Modeling and Cutoff Value of Florfenicol against
Lei Z; Liu Q; Yang S; Yang B; Khaliq H; Li K; Ahmed S; Sajid A; Zhang B; Chen P; Qiu Y; Cao J; He Q
Front Pharmacol; 2018; 9():2. PubMed ID: 29387013
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic-pharmacodynamic integration and modelling of florfenicol in calves.
Sidhu P; Rassouli A; Illambas J; Potter T; Pelligand L; Rycroft A; Lees P
J Vet Pharmacol Ther; 2014 Jun; 37(3):231-42. PubMed ID: 24341543
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic and Pharmacodynamic Evaluation of Marbofloxacin and PK/PD Modeling against
Lei Z; Liu Q; Xiong J; Yang B; Yang S; Zhu Q; Li K; Zhang S; Cao J; He Q
Front Pharmacol; 2017; 8():542. PubMed ID: 28871226
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic-pharmacodynamic modeling of tylosin against Streptococcus suis in pigs.
Huang L; Zhang H; Li M; Ahmad I; Wang Y; Yuan Z
BMC Vet Res; 2018 Oct; 14(1):319. PubMed ID: 30355326
[TBL] [Abstract][Full Text] [Related]
8. Integration of pharmacokinetic-pharmacodynamic for dose optimization of doxycycline against Haemophilus parasuis in pigs.
Zhang L; Li Y; Wang Y; Sajid A; Ahmed S; Li X
J Vet Pharmacol Ther; 2018 Oct; 41(5):706-718. PubMed ID: 29696661
[TBL] [Abstract][Full Text] [Related]
9. Optimization of florfenicol dose against Piscirickettsia salmonis in Salmo salar through PK/PD studies.
San Martín B; Fresno M; Cornejo J; Godoy M; Ibarra R; Vidal R; Araneda M; Anadón A; Lapierre L
PLoS One; 2019; 14(5):e0215174. PubMed ID: 31083666
[TBL] [Abstract][Full Text] [Related]
10. Optimal Regimens and Cutoff Evaluation of Tildipirosin Against
Lei Z; Liu Q; Qi Y; Yang B; Khaliq H; Xiong J; Moku GK; Ahmed S; Li K; Zhang H; Zhang W; Cao J; He Q
Front Pharmacol; 2018; 9():765. PubMed ID: 30093860
[No Abstract] [Full Text] [Related]
11. Optimal regimens based on PK/PD cutoff evaluation of ceftiofur against Actinobacillus pleuropneumoniae in swine.
Sun D; Mi K; Hao H; Xie S; Chen D; Huang L
BMC Vet Res; 2020 Sep; 16(1):366. PubMed ID: 32993661
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic and pharmacodynamic integration and modeling of acetylkitasamycin in swine for Clostridium perfringens.
Nan J; Hao H; Xie S; Pan Y; Xi C; Mao F; Liu Z; Huang L; Yuan Z
J Vet Pharmacol Ther; 2017 Dec; 40(6):641-655. PubMed ID: 28464333
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic and pharmacodynamic modeling of cyadox against Clostridium perfringens in swine.
Yan L; Xie S; Chen D; Pan Y; Tao Y; Qu W; Liu Z; Yuan Z; Huang L
Sci Rep; 2017 Jun; 7(1):4064. PubMed ID: 28642571
[TBL] [Abstract][Full Text] [Related]
14. Response of a clinical Escherichia coli strain to repeated cefquinome exposure in a piglet tissue-cage model.
Gu M; Zhang N; Zhang L; Xiong M; Yang Y; Gu X; Shen X; Ding H
BMC Vet Res; 2015 Jul; 11():169. PubMed ID: 26209108
[TBL] [Abstract][Full Text] [Related]
15. Research Note: Epidemiological cutoff values and acquired resistance mechanisms of three veterinary antibiotics against Escherichia coli from chicken respiratory tract infections.
Zhang HL; Wu SL; Fu JL; Jiang HX; Ding HZ
Poult Sci; 2021 Feb; 100(2):1093-1097. PubMed ID: 33518068
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic/pharmacodynamic integration and modelling of florfenicol for the pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida.
Dorey L; Pelligand L; Cheng Z; Lees P
PLoS One; 2017; 12(5):e0177568. PubMed ID: 28552968
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics, bioavailability and dose assessment of Cefquinome against Escherichia coli in black swans (Cygnus atratus).
Zhao DH; Wang XF; Wang Q; Li LD
BMC Vet Res; 2017 Jul; 13(1):226. PubMed ID: 28754112
[TBL] [Abstract][Full Text] [Related]
18. Bayesian population pharmacokinetic modeling of florfenicol in pigs after intravenous and intramuscular administration.
Liu Z; Rong T; Zeng D; Shen X; Ma X; Zeng Z
J Vet Pharmacol Ther; 2018 Oct; 41(5):719-725. PubMed ID: 29974964
[TBL] [Abstract][Full Text] [Related]
19. Comparative single-dose pharmacokinetics of orally administered florfenicol in rainbow trout (Oncorhynchus mykiss, Walbaum, 1792) at health and experimental infection with Streptococcus iniae or Lactococcus garvieae.
Shiry N; Shomali T; Soltanian S; Akhlaghi M
J Vet Pharmacol Ther; 2019 Mar; 42(2):214-221. PubMed ID: 30474150
[TBL] [Abstract][Full Text] [Related]
20. Plasma concentrations resulting from florfenicol preparations given to pigs in their drinking water.
Gutiérrez L; Vargas D; Ocampo L; Sumano H; Martinez R; Tapia G
J Anim Sci; 2011 Sep; 89(9):2926-31. PubMed ID: 21454858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
